OPC 25 OPC 25 Pill - blue & pink capsule/oblong, 19mm
Generic Name: opicapone
Pill with imprint OPC 25 OPC 25 is Blue & Pink, Capsule/Oblong and has been identified as Ongentys 25 mg. It is supplied by Neurocrine Biosciences, Inc.
Ongentys is used in the treatment of Parkinson's Disease and belongs to the drug class dopaminergic antiparkinsonism agents. Ongentys 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for OPC 25 OPC 25
Ongentys
- Generic Name
- opicapone
- Imprint
- OPC 25 OPC 25
- Strength
- 25 mg
- Color
- Blue & Pink
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Neurocrine Biosciences, Inc.
- National Drug Code (NDC)
- 70370-3025
See also:
Sinemet
Sinemet is used to treat symptoms of Parkinson's disease, such as muscle stiffness, tremors ...
Cogentin
Cogentin is used for extrapyramidal reaction, parkinson's disease
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
Gocovri
Gocovri (amantadine) is used in the treatment of Parkinson's disease. Includes Gocovri side ...
Rivastigmine
Rivastigmine is used for alzheimer's disease, lewy body dementia, parkinson's disease
Levodopa
Levodopa is used for parkinson's disease, parkinsonism, periodic limb movement disorder, restless ...
Amantadine
Easy-to-read patient leaflet for amantadine. Includes indications, proper use, special ...
Carbidopa/levodopa
Carbidopa/levodopa is used for GTP-CH Deficiency, neuroleptic malignant syndrome, parkinson's ...
Benztropine
Benztropine is used for extrapyramidal reaction, hyperhidrosis, parkinson's disease
More about Ongentys (opicapone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.